BlackRock Investment Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 3.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$891,000
-35.2%
374,383
-0.2%
0.00%
-50.0%
Q3 2016$1,376,000
+78.0%
375,016
+8.2%
0.00%
+100.0%
Q2 2016$773,000
+17.5%
346,722
+9.5%
0.00%0.0%
Q1 2016$658,000
-32.2%
316,511
-1.1%
0.00%0.0%
Q4 2015$970,000
+23.9%
320,112
+1.0%
0.00%0.0%
Q3 2015$783,000
-24.6%
316,909
-2.1%
0.00%0.0%
Q2 2015$1,039,000
+0.8%
323,610
+12.1%
0.00%0.0%
Q1 2015$1,031,000
+56.4%
288,736
-0.5%
0.00%0.0%
Q4 2014$659,000
-5.3%
290,262
-19.1%
0.00%0.0%
Q3 2014$696,000
-47.0%
358,627
-0.8%
0.00%
-50.0%
Q2 2014$1,312,000
+13.8%
361,558
+21.7%
0.00%0.0%
Q1 2014$1,153,000
+35.6%
297,076
-0.4%
0.00%
+100.0%
Q4 2013$850,000
-21.9%
298,344
-1.9%
0.00%
-50.0%
Q3 2013$1,089,000
+7.9%
304,203
+0.7%
0.00%0.0%
Q2 2013$1,009,000301,9950.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders